View 3 Images

The weight loss jab Wegovy may help to reduce a person's risk of heart attack or stroke, regardless of how much weight they lose, new research suggests.

The findings suggest the drug could have benefits beyond weight loss and should not only be given to severely obese patients.

However, the research found that losing belly fat appeared to be particularly beneficial for heart health, noting a link between shrinking waistlines and heart benefits.

The study's authors said that an "estimated 33 per cent of the observed benefit on major adverse cardiovascular events was mediated through waist circumference reduction".

Lead author Professor John Deanfield, at UCL Institute of Cardiovascular Science, said: "Abdominal fat is more dangerous for our cardiovascular health than

See Full Page